The American Journal of Medicine
Volume 105, Issue 4 , Pages 275-280 , October 1998

Use of adenosine in patients hospitalized in a university medical center

  • Bradley P Knight, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Bradley P. Knight, MD, University of Michigan Medical Center, 1500 East Medical Center Drive, B1F245-0022, Ann Arbor, Michigan 48109
    • ,
  • Adam Zivin, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    • ,
  • Joseph Souza, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    • ,
  • Rajiva Goyal, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    • ,
  • K.Ching Man (DO)

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    • ,
  • S.Adam Strickberger, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    • ,
  • Fred Morady, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA

Received 4 February 1998 ,Revised 27 May 1998 ,Accepted 27 May 1998.

References 

  1. DiMarco JP, Sellers D, Lerman BB, et al.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol. 1985;6:417–425
  2. for the Adenosine for PSVT Study Group DiMarco JP, Miles W, Akhtar M, et al.  Adenosine for paroxysmal supraventricular tachycardia (dose ranging and comparison with verapamil). Ann Intern Med. 1990;113:104–110
  3. Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia (a randomized double-crossover trial). Am Heart J. 1992;123:1543–1549
  4. Cairns CB, Niemann JT. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20:717–721
  5. Marco CA, Cardinale JF. Adenosine for the treatment of supraventricular tachycardia in the ED. Am J Emerg Med. 1994;12:485–488
  6. Rossi AF, Steinberg GL, Kipel G, et al.  Use of adenosine in the management of perioperative arrhythmias in the pediatric cardiac intensive care unit. Crit Care Med. 1992;20:1107–1111
  7. Brady WJ, DeBehnke DJ, Wickman LL, Lindbeck G. Treatment of out-of-hospital supraventricular tachycardia (adenosine vs verapamil). Acad Emerg Med. 1996;3:574–585
  8. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. NEJM. 1991;325:1621–1629
  9. Rankin AC, Brooks R, Ruskin J, McGovern BA. Adenosine and the treatment of supraventricular tachycardia. Am J Cardiol. 1992;92:655–664
  10. Bigger JT. Cardiac arrhythmias. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia: WB Sanders; 1996:240–241.
  11. Zipes DP. Cardiac arrhythmias. In: Kelley WN, ed. Textbook of Internal Medicine. 3rd ed. Philadelphia: JB Lippincott; 1997:416–417.
  12. Josephson ME, Zimetbaum P, Buxton AE, Marchlinski FE. The tachyarrhythmias. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison’s Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 1998:1264–1265.
  13. Kastor JA. Multifocal atrial tachycardia. NEJM. 1990;322:24:1713–24:1717
  14. Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 4th ed. Philadelphia: WB Saunders; 1992.
  15. Cushley MJ, Tattersfield AE, Holgate ST. Adenosine-induced bronchospasm in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis. 1984;129:380–384
  16. Nunain SO, Garratt C, Paul V, et al.  Effect of intravenous adenosine on human atrial and ventricular repolarisation. Cardiovasc Res. 1992;26:939–943
  17. Tebbenjohanns J, Pfeiffer D, Schumacher B, et al.  Intravenous adenosine during atrioventricular reentrant tachycardia (Induction of atrial fibrillation with rapid conduction over an accessory pathway). PACE. 1995;18:743–746
  18. Exner DV, Muzyka T, Gillis AM. Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine. Ann Intern Med. 1995;122:351–352
  19. Garratt CJ, O’Nunain S, Griffith M, et al.  Effects of intravenous adenosine in patients with preexcited junctional tachycardias (ther-apeutic efficacy and incidence of proarrhythmic events). Am J Cardiol. 1994;74:401–404
  20. Strickberger SA, Man KC, Daoud EG, et al.  Adenosine-induced atrial arrhythmia (a prospective analysis). Ann Intern Med. 1997;127:417–422
  21. Orebaugh SL, Handy M. Intravenous adenosine therapy accelerating rate of paroxysmal supraventricular tachycardia. Am J Emerg Med. 1992;10:326–330
  22. Slade AKB, Garret CJ. Proarrhythmic effect of adenosine in a patient with atrial flutter. Br Heart J. 1993;70:91–92
  23. Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J. 1993;69:263–265
  24. Brodsky MA, Hwang C, Hunter D, et al.  Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J. 1995;130:546–571
  25. Smith JR, Goldberger JJ, Kadish AH. Adenosine induced polymorphic ventricular tachycardia in adults without structural heart disease. PACE. 1997;20:743–745

PII: S0002-9343(98)00261-7

The American Journal of Medicine
Volume 105, Issue 4 , Pages 275-280 , October 1998

Article Tools

* Image Usage & Resolution